Stock Screener · Library
PLIANT THERAPEUTICS, INC. financial statement history
Source-linked financial facts for PLIANT THERAPEUTICS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 221215000 | USD | 2023-03-09 | 2022 / FY | us-gaap:Assets | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 350613000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Assets | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 512154000 | USD | 2025-03-03 | 2024 / FY | us-gaap:Assets | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 396949000 | USD | 2026-03-11 | 2025 / FY | us-gaap:Assets | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 225228000 | USD | 2026-03-11 | 2025 / FY | us-gaap:Assets | 10-K · 0001746473-26-000037 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 209441000 | USD | 2023-03-09 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 340311000 | USD | 2024-02-27 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 505502000 | USD | 2025-03-03 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 362264000 | USD | 2026-03-11 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 196448000 | USD | 2026-03-11 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001746473-26-000037 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 51665000 | USD | 2023-03-09 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 33685000 | USD | 2024-02-27 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 63234000 | USD | 2025-03-03 | 2024 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 71188000 | USD | 2026-03-11 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 45445000 | USD | 2026-03-11 | 2025 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001746473-26-000037 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 4606000 | USD | 2023-03-09 | 2022 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 4486000 | USD | 2024-02-27 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 3567000 | USD | 2025-03-03 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 5525000 | USD | 2026-03-11 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 2940000 | USD | 2026-03-11 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001746473-26-000037 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 22156000 | USD | 2023-03-09 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 37271000 | USD | 2024-02-27 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 38578000 | USD | 2025-03-03 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 92868000 | USD | 2026-03-11 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 44023000 | USD | 2026-03-11 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001746473-26-000037 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 16831000 | USD | 2023-03-09 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 23913000 | USD | 2024-02-27 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 28524000 | USD | 2025-03-03 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 33218000 | USD | 2026-03-11 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 16365000 | USD | 2026-03-11 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001746473-26-000037 |
Long-term debt
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 0 | USD | 2023-03-09 | 2022 / FY | us-gaap:LongTermDebt | 10-K · 0001746473-23-000008 |
| As of 2022-12-31 | 9929000 | USD | 2024-02-27 | 2023 / FY | us-gaap:LongTermDebt | 10-K · 0001746473-24-000043 |
| As of 2023-12-31 | 10054000 | USD | 2025-03-03 | 2024 / FY | us-gaap:LongTermDebt | 10-K · 0001746473-25-000054 |
| As of 2024-12-31 | 30211000 | USD | 2026-03-11 | 2025 / FY | us-gaap:LongTermDebt | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 0 | USD | 2026-03-11 | 2025 / FY | us-gaap:LongTermDebt | 10-K · 0001746473-26-000037 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 199059000 | USD | 2025-03-03 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001746473-25-000054 |
| As of 2022-12-31 | 313342000 | USD | 2025-03-03 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001746473-25-000054 |
| As of 2023-12-31 | 473576000 | USD | 2026-03-11 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001746473-26-000037 |
| As of 2024-12-31 | 304081000 | USD | 2026-03-11 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001746473-26-000037 |
| As of 2025-12-31 | 181205000 | USD | 2026-03-11 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001746473-26-000037 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 7572000 | USD | 2024-02-27 | 2023 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | 9685000 | USD | 2025-03-03 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | 1580000 | USD | 2025-03-03 | 2024 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | 0 | USD | 2026-03-11 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | 0 | USD | 2026-03-11 | 2025 / FY | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | 10-K · 0001746473-26-000037 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 77549000 | USD | 2024-02-27 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | 96936000 | USD | 2025-03-03 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | 127797000 | USD | 2025-03-03 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | 169310000 | USD | 2026-03-11 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | 109157000 | USD | 2026-03-11 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001746473-26-000037 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -97535000 | USD | 2024-02-27 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | -127200000 | USD | 2025-03-03 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | -184145000 | USD | 2025-03-03 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | -228365000 | USD | 2026-03-11 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | -156373000 | USD | 2026-03-11 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001746473-26-000037 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -97263000 | USD | 2024-02-27 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | -123321000 | USD | 2025-03-03 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | -161336000 | USD | 2025-03-03 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | -210304000 | USD | 2026-03-11 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | -149344000 | USD | 2026-03-11 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001746473-26-000037 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -2.71 | USD/shares | 2024-02-27 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | -2.94 | USD/shares | 2025-03-03 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | -2.75 | USD/shares | 2025-03-03 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | -3.47 | USD/shares | 2026-03-11 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | -2.43 | USD/shares | 2026-03-11 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001746473-26-000037 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -75443000 | USD | 2024-02-27 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | -94631000 | USD | 2025-03-03 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | -116361000 | USD | 2025-03-03 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | -155503000 | USD | 2026-03-11 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | -128336000 | USD | 2026-03-11 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001746473-26-000037 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | 1953000 | USD | 2024-02-27 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001746473-24-000043 |
| 2022-01-01 to 2022-12-31 | 1760000 | USD | 2025-03-03 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001746473-25-000054 |
| 2023-01-01 to 2023-12-31 | 921000 | USD | 2025-03-03 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001746473-25-000054 |
| 2024-01-01 to 2024-12-31 | 3848000 | USD | 2026-03-11 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001746473-26-000037 |
| 2025-01-01 to 2025-12-31 | 374000 | USD | 2026-03-11 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001746473-26-000037 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1746473
- Ticker in native snapshot
- PLRX
- Reported numeric facts
- 75
- Units present
- USD · USD/shares